EMAIL DETAILS

Corrado-

I sent your revised proposal to the NU President today. I asked him what the suggested follow up should be (call or visit to Rome as suggestions) and then will loop you in on that.

I will keep you posted.

Best,

Eric


Eric D. Schwerin
Rosemont Seneca Partners, LLC
1010 Wisconsin Ave., NW
Suite 705
Washington, DC 20007
(202) 333-1880
eschwerin@rosemontseneca.com <x-msg://59/eschwerin@obblaw.com>
P Consider the environment before printing this email.


> On Apr 22, 2015, at 5:10 PM, Corrado Cusano <corrado.cusano@medtag.net> wrote:
>
> Yes correct. They can give us space in an existing building or they can build a new one only for this centre.
>
>
> On 22/apr/2015, at 23:06, Eric Schwerin <eschwerin@rosemontseneca.com <mailto:eschwerin@rosemontseneca.com>> wrote:
>
>> Thanks, that is what I thought.
>>
>> One more question, this proposal bears in mind that the University will already be building the building, correct?
>>
>>
>>
>>
>> Eric D. Schwerin
>> Rosemont Seneca Partners, LLC
>> 1010 Wisconsin Ave., NW
>> Suite 705
>> Washington, DC 20007
>> (202) 333-1880
>> Libra Esva ha rilevato un possibile tentativo di phishing da "x-msg:" eschwerin@rosemontseneca.com <x-msg://59/eschwerin@obblaw.com>
>> P Consider the environment before printing this email.
>>
>>
>>
>>
>>> On Apr 22, 2015, at 4:29 PM, Corrado Cusano <corrado.cusano@medtag.net <mailto:corrado.cusano@medtag.net>> wrote:
>>>
>>> Yes. We have reduced only the research projects.
>>> We have kept the full services for the training with simulation.
>>> We have in this proposal only one research project. The building is about 6,000 sqm.
>>> At the end of the story they have a great simulation centre for doctors and nurses and one great research project where they can involve many local researchers. The cost is less than 50mln to set up the project and from the second year the annual fee is 10,5mln.
>>> Let me know if you want more details. I can talk now also if you need. Thanks
>>> Ciao
>>> Corrado
>>>
>>>
>>> On 22/apr/2015, at 22:13, Eric Schwerin <eschwerin@rosemontseneca.com <mailto:eschwerin@rosemontseneca.com>> wrote:
>>>
>>>> Thanks, for making some edits and scaling it back, Corrado.
>>>>
>>>> One question, in the proposal you list the following:
>>>>
>>>> Training offer
>>>> - A portfolio of 200 training programmes
>>>> - Minimum 25 medical specialties
>>>>
>>>> Capacity
>>>> - 8 parallel courses of 20 trainees each
>>>> - 38,500 annual trainees
>>>> Local staff
>>>> - Minimum 80 full-time employees
>>>> - Approximately 400 physicians as consultant trainers
>>>>
>>>> This is the same as the first proposal. Is that correct? Do you still plan to be able to service this many specialties and have this many annual trainees?
>>>>
>>>> Just wanted to check.
>>>>
>>>> Thanks,
>>>>
>>>> Eric
>>>>
>>>>
>>>>
>>>> Eric D. Schwerin
>>>> Rosemont Seneca Partners, LLC
>>>> 1010 Wisconsin Ave., NW
>>>> Suite 705
>>>> Washington, DC 20007
>>>> (202) 333-1880
>>>> Libra Esva ha rilevato un possibile tentativo di phishing da "x-msg:" eschwerin@rosemontseneca.com <x-msg://59/eschwerin@obblaw.com>
>>>> P Consider the environment before printing this email.
>>>>
>>>>
>>>>
>>>>
>>>>> On Apr 22, 2015, at 4:00 PM, Corrado Cusano <corrado.cusano@medtag.net <mailto:corrado.cusano@medtag.net>> wrote:
>>>>>
>>>>> Dear Eric,
>>>>> as agreed, please find attached a new proposal for the Nazarbayev University.
>>>>> We reduce the research projects, now we have one (really cool!).
>>>>> The project is minimum for 5 years.
>>>>> The first year the set up fee is USD 49,6 mln.
>>>>>> From the second year the annual fee is USD 10,5 mln.
>>>>> Please let me know what you think.
>>>>> Ciao
>>>>> Corrado
>>>>>
>>>>>
>>>>> Corrado Cusano
>>>>> President & CEO
>>>>> _________________
>>>>> MEDTAG Ltd
>>>>> England
>>>>> 12, Bridewell Place, 3rd Floor, East Unit
>>>>> London EC4V 6AP
>>>>>
>>>>> www.medtag.net <http://www.medtag.net/>
>>>>>
>>>>> The information transmitted is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination of this information by persons or entities other than the intended recipient is prohibited. If you received this in error, please contact the sender and delete the material from any computer.<Kazakhstan_MedTAG_April 2015.pdf>
>>>>
>>